-+ 0.00%
-+ 0.00%
-+ 0.00%

HC Wainwright & Co. Maintains Buy on Humacyte, Raises Price Target to $4

Benzinga·06/11/2026 15:43:51
Listen to the news
HC Wainwright & Co. analyst Swayampakula Ramakanth maintains Humacyte (NASDAQ:HUMA) with a Buy and raises the price target from $3 to $4.